ASRs and RUOs Market

U.S. ASRs and RUOs Market Outlook 2031

• The U.S. ASRs and RUOs market was valued over US$ 3.6 Bn in 2020
• It is estimated to expand at a CAGR of 4.7% from 2021 to 2031
• The U.S. ASRs and RUOs market is expected to surpass the value of US$ 5.3 Bn by the end of 2031

Analysts’ Viewpoint on U.S. ASRs and RUOs Market

Continuous R&D efforts to reduce morbidity and mortality associated with coronavirus has heightened the demand for diagnostic testing with ASRs & RUOs. The human healthcare segment was found to dominate the revenue share among all end-use applications in the market in 2020. This segment is estimated to register high market attractiveness index by 2031. The segment is anticipated to expand at high CAGR throughout the assessment period. The segment’s dominance can be attributed to increase the use of ASRs and RUOs in specific disease diagnosis, new product development, and increase in research & development activities. Even though the U.S. ASRs and RUOs market is positioned for healthy growth during the forecast period, stakeholders need to seek clarity about stringent regulations regarding commercially distributed ASRs. Hence, stakeholders in the U.S. ASRs and RUOs market should adhere to FDA guidelines and seek clarification of international healthcare organizations to bolster their credibility credentials.

Surge in In-vitro Diagnostic Applications Catalyzing Demand for ASRs

The increase in usage of ASRs (Analyte Specific Reagents) in diagnostic testing helps healthcare providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care. Companies are increasing research in ASR adenovirus probe and ASR adenovirus primer that are used for in-vitro detection of human adenovirus (HAdV)-specific DNA with the help of real-time polymerase chain reaction (PCR).

Rise in usage of ASRs in various diagnostic applications is expected to boost the growth of the ASRs and RUOs market in the U.S. during the forecast period.

Request a sample to get extensive insights into the ASRs and RUOs Market

Increased Importance of Diagnostic Testing with ASRs During COVID-19

ASRs are playing an instrumental role in early development and regulation of diagnostic testing for COVID-19. Such findings are translating into revenue opportunities for healthcare stakeholders. Diagnostic testing is a critical part of the public health response and clinical management of COVID-19, the disease caused by the SARS-CoV-2 virus. In an effort to facilitate the expansion of testing capacity as the first cases of community spread were confirmed in the United States, the Food and Drug Administration (FDA) announced a new COVID 19 diagnostics policy. The new policy, issued via agency guidance and effective immediately, allowed certain laboratories that had developed & validated their own COVID-19 diagnostic to begin to use the test prior to receiving an Emergency Use Authorization (EUA) from the agency.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Technological Advancements Help Boost Experiments with RUOs

ASRs are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents, which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification & quantification of an individual chemical substance or ligand in biological specimens.

Research use only (RUO) means research that is not for profit, internal research, or research for evaluation purposes. Research use only specifically excludes using the product by the licensee in any activity for consideration. According to Transparency Market Research (TMR), the U.S. ASRs and RUOs market is projected to expand at a modest CAGR during the forecast period. Technological advancements are anticipated to drive the U.S. ASRs and RUOs market during the forecast period.

Stuck in a neck-to-neck competition with other brands? Request a custom report on ASRs and RUOs Market

Rise in Prevalence of Infectious Diseases Triggering Demand for ASRs

The U.S. ASRs and RUOs market has witnessed robust growth in the last decade. Technological developments in the field of biotechnology and life sciences are steering the growth of the market. Advancement in technology has expanded the application areas of biotechnology and life sciences, thereby fueling revenue growth of the U.S. ASRs and RUOs market.

The rise in prevalence of infectious diseases, cancer, and hereditary diseases is boosting the demand for diagnostic tools. The surge in use of diagnostic tools such as polymerase chain reaction, hematology, and immunoassay are augmenting the growth of the market.

Technological advancements in the field of cell and tissue culture has increased the usage of ASRs in the areas of microbiology, antibiotics, and diagnostic testing. Moreover, ongoing research & development (R&D) and increase in demand for innovative and breakthrough technologies are propelling income avenues in the U.S. ASRs and RUOs market.

Use of RUOs to Develop Medical Knowledge Related to Human Diseases

RUO means an in-vitro diagnostic product that is in the laboratory research phase of development and is being shipped or delivered for an investigation. Certain products, such as instruments, systems, and reagents, are considered under for research use only products segment.

These products are used to carry out research and not the object of the research. These include products intended for use in discovering and developing medical knowledge related to human diseases and conditions. For instance, instruments and reagents intended for use in research attempting to isolate a gene linked with a particular disease could be labeled for research use only when such instruments & reagents are not intended to produce results for clinical use.

U.S. ASRs and RUOs Market: Overview

• Analyte specific reagents (ASR) are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens.
• Research use only (RUO) means research that is not for profit, internal research, or research for evaluation purposes. Research use only specifically excludes using the product by the licensee in any activity for consideration.
• Technological advancements are anticipated to drive the ASRs and RUOs market in the U.S. during the forecast period

Technological Advancements: Key Driver

• The ASRs and RUOs market in the U.S. has witnessed robust growth in the last decade. Technological developments in the field of biotechnology and life sciences drive the market in the country. Advancement in technology has expanded the application areas of biotechnology and life sciences, thereby fueling the growth of the ASRs and RUOs market.
• Rise in prevalence of infectious diseases, cancer, and hereditary diseases increases the demand for diagnostic tools. Surge in use of diagnostic tools such as polymerase chain reaction (PCR), hematology, and immunoassay augments the market.
• Technological advancements in the field of cell and tissue culture has increased the usage of ASRs in the areas of microbiology, antibiotics, and diagnostic testing. Moreover, ongoing research & development and increase in demand for innovative and breakthrough technologies propel the ASRs and RUOs market in the U.S.

Increase in Usage of ASRs in Diagnostic Applications: Major Driver

• Increase in usage of ASRs in diagnostic testing helps health care providers screen for or monitor specific diseases or conditions. It also helps assess patient health to make clinical decisions for patient care.
• For instance, altona diagnostics’s RealStar ASR Adenovirus Probe and the RealStar ASR Adenovirus Primer are analyte specific reagents (ASR) that are used for in vitro detection of human adenovirus (HAdV) specific DNA by real-time polymerase chain reaction (PCR)
• Increase in usage of ASRs in various diagnostic applications is expected to boost the growth of the ASRs and RUOs market in the U.S. during the forecast period

Human Healthcare Segment to Lead U.S. ASRs and RUOs Market

• The human healthcare segment dominated the market in 2020. The segment is projected to register high market attractiveness index by 2031. The segment is anticipated to expand at high CAGR from 2021 to 2031.
• The segment’s dominance can be attributed to increase in use of ASRs and RUOs in specific disease diagnosis, new product development, and increase in research & development activities

Major Players

• Key players operating in the ASRs and RUOs market in the U.S. include
  • BioLegend, Inc.
  • ELITechGroup
  • BD
  • bioMerieux, Inc.
  • Genetic Signatures
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • DiaSorin Molecular LLC
  • LGC Biosearch Technologies
  • altona Diagnostics GmbH
  • QIAGEN
• Each of these players has been profiled in the ASRs and RUOs market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

U.S. ASRs and RUOs Market Snapshot

U.S. ASRs and RUOs Market – Segmentation

TMR’s study on the ASRs and RUOs market includes information divided into two segments: product type and end-user by application.